Studies show average regain of two-thirds of lost weight within one year, but individual results vary tremendously
Their results suggested that GLP-1RA could inhibit atrial arrhythmogenesis, and improve conducting properties as well as fibrosis in myocardial infarction-induced heart failure
Ongoing monitoring during GLP-1 therapy includes symptom surveillance and, in some cases, periodic lipase or amylase measurement
The dose was started at 3 mg and was escalated to 7 mg and then 14 mg
A Tirzepatide side effect hair loss is generally temporary, with patients experiencing hair regrowth within 3 to 6 months as their bodies adjust to the changes brought on by weight loss, according to clinical research from Does Tirzepatide Cause Hair Loss? by Beverly Tchang in May 2025
In the head-to-head SURMOUNT-5 trial ( NEJM , 2025), Tirzepatide produced 47% greater weight loss than semaglutide at 72 weeks